Global Blood Therapeutics' IPO
Share

Global Blood Therapeutics' IPO

Ted Love, CEO, Global Blood Therapeutics, and CNBC's Meg Tirrell discuss the company's new sickle cell drug.
01:38
Fri, Aug 14 20152:37 PM EDT